C3 and inflammatory bowel disease: Sünderhauf et al. observed that when intestinal mucosal injury and inflammation are active in IBD patients, complement C3 expression is increased, and local C3a production is increased, that in turn propagates pro-in-flammatory cytokine secretion by innate lymphocytes [24].